Peripheral T-cell lymphomas (PTCLs) are a heterogeneous group of clinically aggressive
diseases associated with poor outcome. Studies that focus specifically on PTCL are emerging, …

Castleman disease (CD) describes a group of heterogeneous hematologic disorders with
characteristic histopathological features. CD can present with unicentric or multicentric (MCD) …

Hairy cell leukemia is an uncommon hematologic malignancy characterized by pancytopenia
and marked susceptibility to infection. Tremendous progress in the management of …

Since the publication of the Revised European-American Classification of Lymphoid Neoplasms
in 1994, subsequent updates of the classification of lymphoid neoplasms have been …

Background The role of rituximab in combination with different CHOP (cyclophosphamide,
doxorubicin, vincristine, and prednisone)-like chemotherapy regimens in young patients with …

The prognosis of follicular lymphomas (FL) is heterogeneous and numerous treatments may
be proposed. A validated prognostic index (PI) would help in evaluating and choosing these …

Background Phosphatidylinositol-3-kinase delta (PI3Kδ) mediates B-cell receptor signaling
and microenvironmental support signals that promote the growth and survival of malignant B …

Purpose Hodgkin Reed-Sternberg cells harbor alterations in chromosome 9p24.1, leading
to overexpression of programmed death-ligand 1 (PD-L1) and PD-L2. Pembrolizumab, a …

Background Malignant cells of classical Hodgkin's lymphoma are characterised by genetic
alterations at the 9p24.1 locus, leading to overexpression of PD-1 ligands and evasion of …

Tisagenlecleucel is an autologous anti-CD19 chimeric antigen receptor-T cell therapy with
clinically meaningful outcomes demonstrated in patients with relapsed/refractory (r/r) B-cell …